Medicus Pharma Ltd MDCX
0.15
(0.01)
(6.25%)
as of 25 Sep
- Market cap
- $10.0M
- P/E
- 0.0×
Follow MDCX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
0.92 | 1.00 | 1.22 | 1.57 |
Net Debt/EBITDA |
0.56 | 1.12 | 0.74 | (0.24) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 66.32% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | (10.42) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.32 | 0.44 | 0.97 | 0.61 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.36) | (0.38) | (0.30) | (0.13) | |
Cash per Share |
0.46 | 0.50 | 0.22 | 0.28 | |
Shareholders Equity per Share |
(0.04) | 0.00 | 0.05 | (0.03) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.04) | 0.00 | 0.05 | (0.03) | |
Free Cash Flow |
(6.76) | (6.61) | (8.97) | (6.98) | |
Working Capital |
(0.88) | (0.05) | 1.33 | 6.14 | |
Net Current Asset Value |
(1.00) | (0.13) | 1.28 | (11.86) | |
| Other line items | |||||
Quick Ratio |
0.81 | 0.88 | 1.07 | 1.40 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.36) | (0.38) | (0.30) | (0.13) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.95 | 2.36 | 2.16 | 4.25 | |
Average Assets |
7.85 | 7.85 | 6.54 | 19.53 | |
Average Common Equity |
1.34 | 1.59 | 1.79 | 0.76 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates